The Experts below are selected from a list of 297 Experts worldwide ranked by ideXlab platform
Vijay Zawar - One of the best experts on this subject based on the ideXlab platform.
-
Green Pityriasis Versicolor – A Novel Presentation
Global Journal of Dermatology & Venereology, 2013Co-Authors: Vijay Zawar, Antonio ChuhAbstract:Pityriasis versicolor may present as hypopigmented, hyperpigmented, concomitantly hypo- and hyperpigmented, erythematous, and atrophic subtypes. We report a 15-year-old boy with pruritic greenish plaques on his anterior abdominal wall. Examination under Wood’s light and skin scrapings for KOH smear examination substantiated Pityriasis versicolor. We found no extraneous cause for the greenish pigmentation. The eruptions and the discolouration subsided four weeks after systemic fluconazole treatment. We believe that this represents the first case of such presentation of Pityriasis versicolor. The mechanism of the strange colouration is unknown.
-
Unilateral Pityriasis rosea in a child.
Journal of dermatological case reports, 2010Co-Authors: Vijay ZawarAbstract:Background Various atypical variants of Pityriasis rosea were published in the literature. There are very few reports abour Pityriasis rosea being unilateral.
-
Giant Pityriasis rosea
Indian journal of dermatology, 2010Co-Authors: Vijay ZawarAbstract:Pityriasis rosea is a frequent papulo-squamous disease and is known for various atypical clinical presentations. We report an adult female patient with a clinical diagnosis of giant Pityriasis rosea, which is a rarity in clinical practice.
-
Pityriasis amiantacea-like eruptions in scalp: A novel manifestation of Pityriasis rosea in a child
International journal of trichology, 2010Co-Authors: Vijay ZawarAbstract:Unusual clinical features are known in Pityriasis rosea (PR). We report a case of a child who presented with onset of PR in scalp, clinically mimicking Pityriasis amiantacea. Careful clinical observations and follow-up led us to appropriate diagnosis.
Jimenez J Joaquin - One of the best experts on this subject based on the ideXlab platform.
-
Phototherapy for Pityriasis Lichenoides in the Pediatric Population: A Review of the Published Literature
American Journal of Clinical Dermatology, 2016Co-Authors: Eric L Maranda, Vivek N. Patel, Austin Huy Nguyen, Megan Smith, Lawrence A. Schachner, Jimenez J JoaquinAbstract:Background Pityriasis lichenoides (PL) is a dermatologic disorder that manifests in either the acute (Pityriasis lichenoides et varioliformis acuta) or the chronic form (Pityriasis lichenoides chronica, also known as parapsoriasis chronica). Traditional first-line therapy consists of corticosteroids or antibiotics; however, these treatments are often accompanied with multiple side effects and may be ineffective. Objective The goal of this study was to review the use of phototherapy for treating PL in the pediatric population. Materials and methods We performed a systematic review of the literature in the National Library of Medicine’s PubMed database and the SCOPUS database discussing phototherapy for treatment of PL in the pediatric population. The following search terms were used: ‘Pityriasis lichenoides’, ‘Pityriasis lichenoides chronica’, ‘Pityriasis lichenoides et varioliformis acuta’, and ‘febrile ulceronecrotic Mucha-Habermann disease’. Results The systematic search and screening of articles resulted in 14 articles including a total of 64 patients with PL treated with phototherapy. Three different modalities were utilized, with five studies using broadband ultraviolet B (BB-UVB) radiation, nine studies utilizing narrowband UVB (NB-UVB), and two studies employing psoralen with ultraviolet A (PUVA) therapy. Overall, the use of BB-UVB had an initial clearance rate of 89.6 % with 23.1 % recurrence, whereas NB-UVB cleared 73 % of the lesions with no recurrence, and PUVA therapy initially cleared 83 % of the lesions with 60 % recurrence. The side-effect profiles were similar and revealed limited toxicity. Conclusion Phototherapy shows promising results and a favorable side-effect profile in the treatment of PL. Ultimately, large randomized controlled trials are needed to determine optimal treatments.
-
phototherapy for Pityriasis lichenoides in the pediatric population a review of the published literature
American Journal of Clinical Dermatology, 2016Co-Authors: Eric L Maranda, Austin Huy Nguyen, Megan Smith, V. Patel, Lawrence A. Schachner, Jimenez J JoaquinAbstract:Background Pityriasis lichenoides (PL) is a dermatologic disorder that manifests in either the acute (Pityriasis lichenoides et varioliformis acuta) or the chronic form (Pityriasis lichenoides chronica, also known as parapsoriasis chronica). Traditional first-line therapy consists of corticosteroids or antibiotics; however, these treatments are often accompanied with multiple side effects and may be ineffective.
Erin M. Warshaw - One of the best experts on this subject based on the ideXlab platform.
-
Pityriasis lichenoides and its subtypes
Journal of The American Academy of Dermatology, 2006Co-Authors: Sacharitha Bowers, Erin M. WarshawAbstract:Pityriasis lichenoides represents a unique group of inflammatory skin disorders that include Pityriasis lichenoides et varioliformis acuta (PLEVA), febrile ulceronecrotic Mucha-Habermann disease (a subtype of PLEVA), and Pityriasis lichenoides chronica. The history, epidemiology, clinical features, pathophysiology, and treatment of this group of conditions are reviewed in this manuscript. Learning objective At the completion of this learning activity, participants should be familiar with the clinical manifestations, histopathological findings, proposed mechanisms for pathogenesis, methods of treatment, and potential outcomes of Pityriasis lichenoides and its subtypes.
-
Pityriasis lichenoides and its subtypes.
Journal of the American Academy of Dermatology, 2006Co-Authors: Sacharitha Bowers, Erin M. WarshawAbstract:Pityriasis lichenoides represents a unique group of inflammatory skin disorders that include Pityriasis lichenoides et varioliformis acuta (PLEVA), febrile ulceronecrotic Mucha-Habermann disease (a subtype of PLEVA), and Pityriasis lichenoides chronica. The history, epidemiology, clinical features, pathophysiology, and treatment of this group of conditions are reviewed in this manuscript.
Eric L Maranda - One of the best experts on this subject based on the ideXlab platform.
-
Phototherapy for Pityriasis Lichenoides in the Pediatric Population: A Review of the Published Literature
American Journal of Clinical Dermatology, 2016Co-Authors: Eric L Maranda, Vivek N. Patel, Austin Huy Nguyen, Megan Smith, Lawrence A. Schachner, Jimenez J JoaquinAbstract:Background Pityriasis lichenoides (PL) is a dermatologic disorder that manifests in either the acute (Pityriasis lichenoides et varioliformis acuta) or the chronic form (Pityriasis lichenoides chronica, also known as parapsoriasis chronica). Traditional first-line therapy consists of corticosteroids or antibiotics; however, these treatments are often accompanied with multiple side effects and may be ineffective. Objective The goal of this study was to review the use of phototherapy for treating PL in the pediatric population. Materials and methods We performed a systematic review of the literature in the National Library of Medicine’s PubMed database and the SCOPUS database discussing phototherapy for treatment of PL in the pediatric population. The following search terms were used: ‘Pityriasis lichenoides’, ‘Pityriasis lichenoides chronica’, ‘Pityriasis lichenoides et varioliformis acuta’, and ‘febrile ulceronecrotic Mucha-Habermann disease’. Results The systematic search and screening of articles resulted in 14 articles including a total of 64 patients with PL treated with phototherapy. Three different modalities were utilized, with five studies using broadband ultraviolet B (BB-UVB) radiation, nine studies utilizing narrowband UVB (NB-UVB), and two studies employing psoralen with ultraviolet A (PUVA) therapy. Overall, the use of BB-UVB had an initial clearance rate of 89.6 % with 23.1 % recurrence, whereas NB-UVB cleared 73 % of the lesions with no recurrence, and PUVA therapy initially cleared 83 % of the lesions with 60 % recurrence. The side-effect profiles were similar and revealed limited toxicity. Conclusion Phototherapy shows promising results and a favorable side-effect profile in the treatment of PL. Ultimately, large randomized controlled trials are needed to determine optimal treatments.
-
phototherapy for Pityriasis lichenoides in the pediatric population a review of the published literature
American Journal of Clinical Dermatology, 2016Co-Authors: Eric L Maranda, Austin Huy Nguyen, Megan Smith, V. Patel, Lawrence A. Schachner, Jimenez J JoaquinAbstract:Background Pityriasis lichenoides (PL) is a dermatologic disorder that manifests in either the acute (Pityriasis lichenoides et varioliformis acuta) or the chronic form (Pityriasis lichenoides chronica, also known as parapsoriasis chronica). Traditional first-line therapy consists of corticosteroids or antibiotics; however, these treatments are often accompanied with multiple side effects and may be ineffective.
Austin Huy Nguyen - One of the best experts on this subject based on the ideXlab platform.
-
Phototherapy for Pityriasis Lichenoides in the Pediatric Population: A Review of the Published Literature
American Journal of Clinical Dermatology, 2016Co-Authors: Eric L Maranda, Vivek N. Patel, Austin Huy Nguyen, Megan Smith, Lawrence A. Schachner, Jimenez J JoaquinAbstract:Background Pityriasis lichenoides (PL) is a dermatologic disorder that manifests in either the acute (Pityriasis lichenoides et varioliformis acuta) or the chronic form (Pityriasis lichenoides chronica, also known as parapsoriasis chronica). Traditional first-line therapy consists of corticosteroids or antibiotics; however, these treatments are often accompanied with multiple side effects and may be ineffective. Objective The goal of this study was to review the use of phototherapy for treating PL in the pediatric population. Materials and methods We performed a systematic review of the literature in the National Library of Medicine’s PubMed database and the SCOPUS database discussing phototherapy for treatment of PL in the pediatric population. The following search terms were used: ‘Pityriasis lichenoides’, ‘Pityriasis lichenoides chronica’, ‘Pityriasis lichenoides et varioliformis acuta’, and ‘febrile ulceronecrotic Mucha-Habermann disease’. Results The systematic search and screening of articles resulted in 14 articles including a total of 64 patients with PL treated with phototherapy. Three different modalities were utilized, with five studies using broadband ultraviolet B (BB-UVB) radiation, nine studies utilizing narrowband UVB (NB-UVB), and two studies employing psoralen with ultraviolet A (PUVA) therapy. Overall, the use of BB-UVB had an initial clearance rate of 89.6 % with 23.1 % recurrence, whereas NB-UVB cleared 73 % of the lesions with no recurrence, and PUVA therapy initially cleared 83 % of the lesions with 60 % recurrence. The side-effect profiles were similar and revealed limited toxicity. Conclusion Phototherapy shows promising results and a favorable side-effect profile in the treatment of PL. Ultimately, large randomized controlled trials are needed to determine optimal treatments.
-
phototherapy for Pityriasis lichenoides in the pediatric population a review of the published literature
American Journal of Clinical Dermatology, 2016Co-Authors: Eric L Maranda, Austin Huy Nguyen, Megan Smith, V. Patel, Lawrence A. Schachner, Jimenez J JoaquinAbstract:Background Pityriasis lichenoides (PL) is a dermatologic disorder that manifests in either the acute (Pityriasis lichenoides et varioliformis acuta) or the chronic form (Pityriasis lichenoides chronica, also known as parapsoriasis chronica). Traditional first-line therapy consists of corticosteroids or antibiotics; however, these treatments are often accompanied with multiple side effects and may be ineffective.
